Sliding scale regimen versus basal bolus insulin regime for hyperglycemia management in hospitalized patients with type 2 diabetes
International Journal of Medical Toxicology and Forensic Medicine · 11.03.2026
DOI: 10.22037/ijmtfm.v16.50965 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Toxicology and Forensic Medicine, erschienen am 11.03.2026. Verfasst von Sarah Jaafar Saadoon und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Since type-2 diabetes mellitus (T2DM) is becoming more common, it is crucial to implement an appropriate care plan for these patients' hyperglycemia to lower the risk of complications. While Sliding Scale Insulin (SSI) has been the traditional approach, Basal-bolus insulin (BBI) therapy is a promising strategy and is increasingly recommended. We aimed to compare the efficacy of SSI versus BBI regimens in hospitalized patients with T2DM.
Methods
The demographics, complications, and type of insulin therapy for type 2 diabetic hospitalized patients were recorded from patients’ archived documents.
Results
We observed that 59.7% of the patients were treated for SSI accompanied by macrovascular complications. While 37.8% of patients treated with BBI had macrovascular complications, the difference between the BBI & SSI groups was statistically significant. For microvascular complications, also, a statistically significant difference was detected between the BBI & SSI groups (P-value = 0.001). Only 18.6% & 17.2% of the patients developed hypoglycemia in the BBI group & SSI group, respectively. We evaluated the efficacy of both treatments on daily random blood glucose (RBG) in our patients for 1 week; a slight decrease in RBG was observed between the first & the seventh days of treatment in the SSI group. An obvious improvement was observed in the BBI, indicating that BBI was more effective at controlling RBG than SSI.
Conclusion
Our study demonstrated that BBI therapy was superior to SSI therapy in achieving ideal blood glucose levels, with fewer hypoglycemic episodes and cardiovascular events.
Schlagwörter
Zitieren
APA
Saadoon, S. J., Al-Anbari, H. H., Jabbar, T. L., & Mostafa, F. M. (2026). Sliding scale regimen versus basal bolus insulin regime for hyperglycemia management in hospitalized patients with type 2 diabetes. International Journal of Medical Toxicology and Forensic Medicine. https://doi.org/10.22037/ijmtfm.v16.50965
Vancouver
Saadoon SJ, Al-Anbari HH, Jabbar TL, Mostafa FM. Sliding scale regimen versus basal bolus insulin regime for hyperglycemia management in hospitalized patients with type 2 diabetes. International Journal of Medical Toxicology and Forensic Medicine. 2026. doi:10.22037/ijmtfm.v16.50965
BibTeX
@article{Saadoon2026,
author = {Saadoon, Sarah Jaafar and Al-Anbari, Hayder Hamid and Jabbar, Thair L. and Mostafa, Fatma M.},
title = {Sliding scale regimen versus basal bolus insulin regime for hyperglycemia management in hospitalized patients with type 2 diabetes},
journal = {International Journal of Medical Toxicology and Forensic Medicine},
year = {2026},
doi = {10.22037/ijmtfm.v16.50965}
}
EUVIMED